Mangoceuticals (MGRX) Other Gross PP&E Adjustments (2022 - 2026)
Mangoceuticals recorded quarterly Other Gross PP&E Adjustments of -$333374.0 in Q1 2026, up 89.12% quarter-over-quarter from -$3.1 million in Q4 2025, and down 103.78% year-over-year from $8.8 million in Q1 2025.
Mangoceuticals' Other Gross PP&E Adjustments history runs 5 years deep, the most recent figure standing at -$333374.0 for Q1 2026.
- In Q1 2026, Other Gross PP&E Adjustments fell 103.78% year-over-year to -$333374.0; the TTM figure through Mar 2026 stood at -$333374.0 (down 103.78% YoY), while the FY2025 annual figure was -$3.1 million, down 204.39% from the prior year.
- Other Gross PP&E Adjustments came in at -$333374.0 for Q1 2026 at Mangoceuticals, up from -$3.1 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of $15027.0 in Q1 2024 to a low of -$3.1 million in Q4 2025.
- A 5-year average of -$455941.1 and a median of -$137558.0 in 2023 frame the typical range for Other Gross PP&E Adjustments.
- On a YoY basis, Other Gross PP&E Adjustments climbed as much as 109.64% in 2024 and fell as far as 1330.38% in 2024.
- Mangoceuticals' Other Gross PP&E Adjustments stood at -$57941.0 in 2022, then tumbled by 105.83% to -$119262.0 in 2023, then plunged by 744.07% to -$1.0 million in 2024, then plunged by 204.39% to -$3.1 million in 2025, then soared by 89.12% to -$333374.0 in 2026.
- According to Business Quant data, Other Gross PP&E Adjustments over the past three periods registered -$333374.0, -$3.1 million, and -$16273.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | -54.30 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | -173.33 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 6.94 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | 25.09 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 32.85 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 153.49 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | 323.15 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | -17.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 289.75 Mn |
| 10 | Mangoceuticals | 7.03 Mn | 6.84 Mn | 29,001.00 | -333,374.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -333,374.00 |
| Mar 31, 2026 | -333,374.00 |
| Dec 31, 2025 | -3.07 Mn |
| Dec 31, 2025 | -3.07 Mn |
| Sep 30, 2025 | -16,273.00 |
| Sep 30, 2025 | -16,273.00 |
| Jun 30, 2025 | -32,732.00 |
| Jun 30, 2025 | -32,732.00 |
| Mar 31, 2025 | -163,593.00 |
| Mar 31, 2025 | -163,593.00 |
| Dec 31, 2024 | -1.01 Mn |
| Dec 31, 2024 | -1.01 Mn |
| Sep 30, 2024 | -194,732.00 |
| Sep 30, 2024 | -194,732.00 |
| Jun 30, 2024 | -209,830.00 |
| Jun 30, 2024 | -209,830.00 |
| Mar 31, 2024 | -99,730.00 |
| Mar 31, 2024 | -99,730.00 |
| Dec 31, 2023 | -234,019.00 |
| Dec 31, 2023 | -234,019.00 |
| Sep 30, 2023 | -128,371.00 |
| Sep 30, 2023 | -128,371.00 |
| Jun 30, 2023 | -27,340.00 |
| Jun 30, 2023 | -27,340.00 |
| Mar 31, 2023 | -41,097.00 |
| Mar 31, 2023 | -41,097.00 |
| Dec 31, 2022 | -169,179.00 |
| Dec 31, 2022 | -169,179.00 |